RT @CochraneLibrary: 👶 Podcast: Prophylactic cyclo-oxygenase inhibitor drugs to prevent morbidity and mortality in preterm infants 🎧 List…

👶 Podcast: Prophylactic cyclo-oxygenase inhibitor drugs to prevent morbidity and mortality in preterm infants 🎧 Listen to the #CochranePodcast https://t.co/HYwBpR301p 🌟 Also on @Spotify & @ApplePodcasts 📚 Based on @CochraneNeonate systematic review

RT @souvik_neo: @NICU_Musings Not surprised by the effect on severe IVH. In our recent @CochraneNeonate NMA we found that the absolute risk…

RT @souvik_neo: @NICU_Musings Not surprised by the effect on severe IVH. In our recent @CochraneNeonate NMA we found that the absolute risk…

@NICU_Musings Not surprised by the effect on severe IVH. In our recent @CochraneNeonate NMA we found that the absolute risk reduction (& certainty of the estimate) for severe IVH was identical for both prophylactic indomethacin & ibuprofen. https:/

RT @autismepi: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network met…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis https://t.co/sZrFFIPojh The evidence is very uncertain about the effect of #acetaminophen (Tylenol) on any of the clin

早産児の罹患および死亡を予防するためのシクロオキシゲナーゼ阻害剤の予防的投与 Prophylactic cyclo-oxygenase inhibitor drugs to prevent morbidity and mortality in preterm infants (Cochrane Review Plain language summary) #Cochrane #CochraneJapan

RT @CochraneJapan: 早産児の罹患および死亡を予防するためのシクロオキシゲナーゼ阻害剤の予防的投与 https://t.co/kolB0AHVA6

RT @CochraneJapan: 早産児の罹患および死亡を予防するためのシクロオキシゲナーゼ阻害剤の予防的投与 https://t.co/kolB0AHVA6

RT @CochraneJapan: 早産児の罹患および死亡を予防するためのシクロオキシゲナーゼ阻害剤の予防的投与 https://t.co/kolB0AHVA6

早産児の罹患および死亡を予防するためのシクロオキシゲナーゼ阻害剤の予防的投与 https://t.co/kolB0AHVA6

@GuyattGH 💯 agree! We recently published this NMA on @CochraneNeonate where we defined thresholds of benefit/harm using a partially contextualized approach prior to assessing #GRADE certainty of evidence https://t.co/MVoPdMlbfU

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

RT @souvik_neo: Are we certain enough to adopt or discard their use without involving parents? Our guideline panel including @JonDorling18…

RT @CochraneIberoam: ¿Cuál fármaco profiláctico inhibidor de la ciclooxigenasa es el más seguro para la prevención de la morbilidad y la mo…

RT @CochraneIberoam: ¿Cuál fármaco profiláctico inhibidor de la ciclooxigenasa es el más seguro para la prevención de la morbilidad y la mo…

RT @CochraneIberoam: ¿Cuál fármaco profiláctico inhibidor de la ciclooxigenasa es el más seguro para la prevención de la morbilidad y la mo…

RT @CochraneIberoam: ¿Cuál fármaco profiláctico inhibidor de la ciclooxigenasa es el más seguro para la prevención de la morbilidad y la mo…

RT @souvik_neo: Are we certain enough to adopt or discard their use without involving parents? Our guideline panel including @JonDorling18…

RT @CochraneIberoam: ¿Cuál fármaco profiláctico inhibidor de la ciclooxigenasa es el más seguro para la prevención de la morbilidad y la mo…

RT @CochraneIberoam: ¿Cuál fármaco profiláctico inhibidor de la ciclooxigenasa es el más seguro para la prevención de la morbilidad y la mo…

¿Cuál fármaco profiláctico inhibidor de la ciclooxigenasa es el más seguro para la prevención de la morbilidad y la mortalidad en #neonatos prematuros? Mira el nuevo #metanálisis en red que responde a esta pregunta 👉 https://t.co/fNw9Pj4chA https://t.co/

RT @souvik_neo: Are we certain enough to adopt or discard their use without involving parents? Our guideline panel including @JonDorling18…

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

RT @souvik_neo: Are we certain enough to adopt or discard their use without involving parents? Our guideline panel including @JonDorling18…

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

RT @souvik_neo: Are we certain enough to adopt or discard their use without involving parents? Our guideline panel including @JonDorling18…

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis #NeoPapers #neoTwitter https://t.co/EQbfPsaZfA

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

Are we certain enough to adopt or discard their use without involving parents? Our guideline panel including @JonDorling18 @methodsnerd @DrCGale @DrMCampbellYeo @Rebekah__Nixon @Neo_FICareIWK & others just finished brainstorming using @GRADEproGDT EtD

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

RT @EBNEO: .@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for pre…

.@souvik_neo et al's latest @CochraneNeonate network meta-analysis evaluates the use of prophylactic COX inhibitor drugs for prevention of morbidity and mortality in preterm infants. Link to article: https://t.co/QvXzfUuP0C #neoEBM #EBNEOalerts #neotwitte

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis https://t.co/gr2tuetRpL

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis #NeoPapers #neoTwitter https://t.co/X8yawgpcXx

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis https://t.co/3zok0E5gWW

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis #NeoPapers #neoTwitter https://t.co/7llcGPv2iO

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis https://t.co/rHkYCm9Qw0

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis #NeoPapers #neoTwitter https://t.co/sXNWoE4PPl

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis https://t.co/BIp1WagDlO

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis #NeoPapers #neoTwitter https://t.co/gFRfWj0ZoS

RT @ESPR_EBN: Neonatal Publication Highlight: New @CochraneNeonate SR-NMA on prophylactic COX-Inhibitors for prevention of mortality & mor…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis https://t.co/uGPlpJ95Ot

RT @ESPR_EBN: Neonatal Publication Highlight: New @CochraneNeonate SR-NMA on prophylactic COX-Inhibitors for prevention of mortality & mor…

RT @ESPR_EBN: Neonatal Publication Highlight: New @CochraneNeonate SR-NMA on prophylactic COX-Inhibitors for prevention of mortality & mor…

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

RT @neo_papers: Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network me…

Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis #NeoPapers #neoTwitter https://t.co/RFb3YznVeK

RT @ESPR_EBN: Neonatal Publication Highlight: New @CochraneNeonate SR-NMA on prophylactic COX-Inhibitors for prevention of mortality & mor…

RT @ESPR_EBN: Neonatal Publication Highlight: New @CochraneNeonate SR-NMA on prophylactic COX-Inhibitors for prevention of mortality & mor…

RT @ESPR_EBN: Neonatal Publication Highlight: New @CochraneNeonate SR-NMA on prophylactic COX-Inhibitors for prevention of mortality & mor…

Neonatal Publication Highlight: New @CochraneNeonate SR-NMA on prophylactic COX-Inhibitors for prevention of mortality & morbidity in preterm infants by @souvik_neo et al. https://t.co/MK99alfoHS 3999 🚼 in 28 RCTs: 2877 Indomethacin, 914 Ibuprofen,

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

RT @souvik_neo: Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63…

Our @CochraneNeonate network meta-analysis on prophylactic COX-I meds in preterms is finally out. https://t.co/kAA3WnIO63 Huge thanks to @JonDorling18 @DrMCampbellYeo @halifaxtim @methodsnerd @abbeymaclellan & team! Looking forward to discussion at @P